Safe Harbor Fiduciary’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
1,861
+19
+1% +$19.3K 1.63% 22
2025
Q4
$1.98M Buy
+1,842
New +$1.76M 1.75% 16
2025
Q2
$1.43M Buy
1,830
+77
+4% +$59.8K 1.34% 20
2025
Q1
$1.45M Sell
1,753
-5
-0.3% -$4.16K 1.5% 20
2024
Q4
$1.36M Buy
1,758
+20
+1% +$16.6K 1.38% 20
2024
Q3
$1.54M Buy
+1,738
New +$1.56M 1.44% 16

Other funds holding LLY

Safe Harbor Fiduciary's LLY Position: Q1 2026 in Review

Safe Harbor Fiduciary increased its Eli Lilly (LLY) stake by 1% in Q1 2026, buying an estimated $19.3K and bringing the position to 1,861 shares worth $1.71M. The position accounts for 1.63% of the portfolio, ranked #22.

Safe Harbor Fiduciary first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.98M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Safe Harbor Fiduciary held 1,861 shares of Eli Lilly worth $1.71M as of Q1 2026.
  • Safe Harbor Fiduciary bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 1.63% of Safe Harbor Fiduciary's portfolio in Q1 2026, its #22 holding.
  • Safe Harbor Fiduciary first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • Safe Harbor Fiduciary's Eli Lilly position peaked at $1.98M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Safe Harbor Fiduciary's 13F filing for Q1 2026, filed 15 May 2026.